Royal Bank of Canada Has $18.64 Million Position in iShares Global Healthcare ETF $IXJ

Royal Bank of Canada cut its holdings in shares of iShares Global Healthcare ETF (NYSEARCA:IXJ) by 7.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 199,252 shares of the company’s stock after selling 16,384 shares during the quarter. Royal Bank of Canada’s holdings in iShares Global Healthcare ETF were worth $18,637,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Nvest Wealth Strategies Inc. acquired a new position in iShares Global Healthcare ETF in the 4th quarter valued at approximately $30,000. Franklin Resources Inc. lifted its holdings in shares of iShares Global Healthcare ETF by 80.0% during the second quarter. Franklin Resources Inc. now owns 360 shares of the company’s stock worth $31,000 after purchasing an additional 160 shares during the period. Arax Advisory Partners bought a new stake in shares of iShares Global Healthcare ETF in the fourth quarter worth $31,000. LOM Asset Management Ltd grew its stake in shares of iShares Global Healthcare ETF by 37.0% in the fourth quarter. LOM Asset Management Ltd now owns 407 shares of the company’s stock worth $40,000 after purchasing an additional 110 shares during the last quarter. Finally, Capital Investment Counsel Inc bought a new stake in shares of iShares Global Healthcare ETF in the fourth quarter worth $42,000.

iShares Global Healthcare ETF Stock Up 0.2%

NYSEARCA IXJ opened at $101.27 on Friday. The company has a market capitalization of $4.14 billion, a price-to-earnings ratio of 21.58 and a beta of 0.56. iShares Global Healthcare ETF has a twelve month low of $82.16 and a twelve month high of $103.40. The stock has a fifty day simple moving average of $97.78 and a 200 day simple moving average of $96.57.

About iShares Global Healthcare ETF

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.